Article Details
Retrieved on: 2022-05-19 11:19:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Moderna and IAVI are set to commence Phase I IAVI G003 clinical trial of a mRNA HIV vaccine antigen, mRNA-1644, in Rwanda and South Africa.
Article found on: www.clinicaltrialsarena.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here